Ematik System

Ematik is a product line developed by Prometheus, an Italian biotech company founded in 2017. The company's flagship product, Ematik Patch, is a resorbable and personalized patch designed for treating severe lesions such as sores, burns, and ulcers. This innovative patch combines the patient's blood with 3D-printed biopolymers, reportedly halving healing times without leaving scars. Prometheus has developed an automated system that extracts active molecules from the patient's blood and combines them with biopolymers provided to the doctor in a single-use kit, producing a ready-to-use patch in minutes. Ematik products were already being used in the veterinary sector through a collaboration with multinational company B. Braun. The company aims to expand its product offerings to include new kits for orthopedics, aesthetic medicine, and dentistry markets. Prometheus has completed the preclinical phase for certifying Ematik devices for human use and has been working toward obtaining CE marking for use in the hospital sector.

Key customers and partnerships

Ematik products have found application in the veterinary sector through a partnership with B. Braun, a multinational company. The collaboration has enabled the commercialization of Ematik products for animal care. In the human healthcare market, Prometheus is targeting hospitals and clinics, both public and private. There were 22,000 healthcare facilities in Europe, with daily patient inflow in centers with vulnology departments estimated at around 60 patients per day, or more than 10,000 per year. The company has also garnered interest from notable figures in the medical field, including Andrea Chiesi of Chiesi Farmaceutici Spa and Professor Antonino di Pietro, a dermatologist and expert in clinical and aesthetic treatments, who has shown interest in a new kit for wrinkle treatment and hair regrowth.